Marker Therapeutics, Inc.
MRKR
$1.60
$0.031.91%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 5.70M | 6.59M | 5.40M | 3.73M | 3.32M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 5.70M | 6.59M | 5.40M | 3.73M | 3.32M |
Cost of Revenue | 14.03M | 13.47M | 11.00M | 9.57M | 9.62M |
Gross Profit | -8.33M | -6.88M | -5.60M | -5.85M | -6.29M |
SG&A Expenses | 4.39M | 4.24M | 4.59M | 5.15M | 6.53M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 18.42M | 17.71M | 15.59M | 14.72M | 16.14M |
Operating Income | -12.72M | -11.12M | -10.19M | -10.99M | -12.82M |
Income Before Tax | -12.73M | -10.68M | -9.63M | -10.30M | -12.21M |
Income Tax Expenses | 50.00K | 50.00K | 3.70K | 3.70K | 3.70K |
Earnings from Continuing Operations | -12.78 | -10.73 | -9.63 | -10.31 | -12.21 |
Earnings from Discontinued Operations | -- | -- | -62.90K | -62.90K | 6.55M |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -12.78M | -10.73M | -9.70M | -10.37M | -5.66M |
EBIT | -12.72M | -11.12M | -10.19M | -10.99M | -12.82M |
EBITDA | -- | -- | -2.24M | -4.74M | -8.06M |
EPS Basic | -1.32 | -1.19 | -1.09 | -1.17 | -0.64 |
Normalized Basic EPS | -0.80 | -0.74 | -0.68 | -0.73 | -0.86 |
EPS Diluted | -1.33 | -1.20 | -1.09 | -1.17 | -0.64 |
Normalized Diluted EPS | -0.80 | -0.74 | -0.68 | -0.73 | -0.86 |
Average Basic Shares Outstanding | 38.12M | 35.92M | 35.63M | 35.54M | 35.42M |
Average Diluted Shares Outstanding | 38.12M | 35.92M | 35.63M | 35.54M | 35.42M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |